Introduction {#s1}
============

Calcium (Ca^2+^) is a ubiquitous and universal intracellular signal whose remarkable biological versatility is a product of diverse patterns of spatial and temporal regulation ([@bib93]; [@bib10]; [@bib28]), most notably in the form of repetitive, transient elevations in cytosolic Ca^2+^ concentrations, or Ca^2+^ oscillations. In general, oscillatory signals are thought to function as a critical biological regulator by allowing a single message to encode multiple types of information through variations in the frequency, amplitude, and spatial characteristics of the signal ([@bib19]; [@bib32]), thereby promoting specificity in the regulation of downstream targets. Ca^2+^ oscillations in particular are known to regulate numerous processes including gene expression ([@bib64]; [@bib51]), exocytosis ([@bib97]; [@bib71]), and excitation-contraction coupling ([@bib99]; [@bib57]), and Ca^2+^ oscillations have been shown to significantly enhance the specificity and efficiency of Ca^2+^-regulated processes ([@bib27]; [@bib54]; [@bib48]). Cells are primarily dependent on a single effector protein, the Ca^2+^ sensor calmodulin (CaM), to transduce Ca^2+^ signals. CaM sits at the epicenter of Ca^2+^ signaling, modulating the activity of a vast array of target proteins throughout the cell ([@bib73]). CaM is also thought to play a prominent role in the decoding of Ca^2+^ oscillations, largely via the differential activation of target proteins such as the Ca^2+^- and CaM-dependent phosphatase calcineurin ([@bib82]; [@bib87]; [@bib70]; [@bib85]).

One of the major targets of CaM in almost all eukaryotic cells ([@bib41]), calcineurin is involved in regulating diverse physiological processes, including cell proliferation, differentiation, and death, as well as gene expression, secretion, immune function, learning, and memory (reviewed in [@bib79]; [@bib3]). However, the precise spatiotemporal regulation of calcineurin signaling remains poorly understood. Ca^2+^ oscillations have previously been shown to enhance calcineurin-mediated transcriptional regulation ([@bib27]; [@bib54]; [@bib95]; [@bib105]), and studies have also shown that the Ca^2+^ oscillatory frequency is a critical determinant of calcineurin-dependent hypertrophic signaling in cardiomyocytes ([@bib20]; [@bib82]) and long-term depression in neurons ([@bib60]; [@bib53]; [@bib31]). Nevertheless, the precise relationship between Ca^2+^ oscillations and calcineurin signaling has yet to be elucidated. Similarly, calcineurin dephosphorylates multiple target proteins located throughout the cell ([@bib15]; [@bib100]; [@bib6]; [@bib17]; [@bib90]; [@bib13]), and although spatial compartmentalization is suspected to play an important role in regulating calcineurin signaling ([@bib37]), this phenomenon has yet to be directly examined.

Both Ca^2+^ oscillations and calcineurin signaling are known to play important roles in pancreatic β-cells. Ca^2+^ oscillations are responsible for driving the pulsatile secretion of insulin ([@bib40]; [@bib91]), and the chronic inhibition of calcineurin, which is a common form of immunosuppressive therapy, is often accompanied by the onset of diabetes ([@bib38]; [@bib18]). In the present study, we use a variety of genetically encoded fluorescent reporters to directly investigate the spatiotemporal dynamics of calcineurin signaling in response to cytosolic Ca^2+^ oscillations in MIN6 β-cells. We were able to observe distinct subcellular patterns of calcineurin activity in the cytosol and plasma membrane, where calcineurin appeared to integrate the oscillatory input, vs at the ER and mitochondrial surfaces, where calcineurin activity was observed to oscillate. Furthermore, an exploration of the molecular determinants involved in regulating calcineurin activity revealed that significant differences in the subcellular distribution of free Ca^2+^/CaM are responsible for generating these discrete activity patterns. Our findings provide the first evidence that oscillatory signals are capable of differentially regulating calcineurin activity and suggest a more active role for CaM in transducing oscillatory Ca^2+^ signals.

Results {#s2}
=======

Distinct zones of subcellular calcineurin activity in MIN6 cells {#s2-1}
----------------------------------------------------------------

To investigate the spatiotemporal regulation of calcineurin signaling in response to Ca^2+^ oscillations in β-cells, we engineered an improved version of our previously described FRET-based calcineurin activity reporter (CaNAR) ([@bib65]) by optimizing the donor and acceptor fluorescent protein pair ([Figure 1](#fig1){ref-type="fig"}). We then targeted this reporter, called CaNAR2, to the cytosol (cytoCaNAR2), plasma membrane (pmCaNAR2), mitochondrial outer membrane (mitoCaNAR2), and ER surface (erCaNAR2) via in-frame fusion with a C-terminal nuclear export signal (NES) ([@bib98]), an N-terminal motif derived from Lyn kinase (Lyn) ([@bib33]; [@bib25]), an N-terminal motif derived from DAKAP1a (DAKAP) ([@bib26]), and an N-terminal motif derived from cytochrome P450 (CYP450) ([@bib88]), respectively ([Figure 2A--E](#fig2){ref-type="fig"}). Each targeted CaNAR2 variant was co-expressed in MIN6 β-cells along with a diffusible version of the genetically encoded, red-fluorescent Ca^2+^ indicator RCaMP ([@bib2]), allowing us to simultaneously visualize and characterize the coordination of subcellular calcineurin activity with cytosolic Ca^2+^ levels. Membrane depolarization induced by tetraethylammonium chloride (TEA) treatment produced robust oscillations in RCaMP fluorescence intensity, which were consistent with the cytosolic Ca^2+^ oscillations previously observed in MIN6 cells ([@bib49]; [@bib67]) ([Figure 2F--I](#fig2){ref-type="fig"}, red curves).10.7554/eLife.03765.003Figure 1.Development and characterization of CaNAR2.(**A**) Schematic depicting the CaNAR variants tested. FRET pair optimization was performed by replacing the original ECFP and circularly permuted Venus (cpV) L194 of CaNAR1 (top) with Cerulean, Cerulean2, Cerulean3, cpV E172, or YPet. The responses from each construct are indicated as follows: +, ∼5--10%; ++, ∼10--15%; +++, ∼15--20%; ++++, \>20%. (**B** and **C**) Representative time-courses comparing the yellow/cyan (Y/C) emission ratio changes from CaNAR1 and CaNAR2 in HEK293 cells treated with (**B**) 1 μM thapsigargin (TG) or (**C**) 1 μM ionomycin (iono). CaNAR2 exhibits an at least twofold greater response in each condition. (**D** and **E**) Pseudocolored images showing the responses of CaNAR1 and CaNAR2 to (**D**) 1 μM TG or (**E**) 1 μM iono in HEK293 cells. Warmer colors correspond to higher FRET ratios. Cyan fluorescence images (left) show the cellular distribution of CaNAR1 and CaNAR2 fluorescence.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.003](10.7554/eLife.03765.003)10.7554/eLife.03765.004Figure 2.Subcellular calcineurin activity dynamics in response to Ca^2+^ oscillations in MIN6 cells.(**A**) Schematic illustrating the domain structures of the subcellularly targeted variants of the CaNAR2 biosensor. (**B** and **C**) Yellow fluorescence images showing the biosensor distribution in transiently transfected MIN6 cells expressing (**B**) cytoCaNAR2 and (**C**) pmCaNAR2. (**D** and **E**) Fluorescence images showing the localization of mitoCaNAR2 and erCaNAR2. MIN6 cells expressing (**D**) mitoCaNAR2 or (**E**) erCaNAR2 were stained with MitoTracker Red or ER-Tracker Red, respectively. Image series corresponds to biosensor fluorescence (YFP, left), dye fluorescence (middle), and merged (right). (**F**--**I**) Representative time-courses showing the yellow/cyan (Y/C) emission ratio changes from (**F**) cytoCaNAR2 (n = 29), (**G**) pmCaNAR2 (n = 22), (**H**) mitoCaNAR2 (n = 11), and (**I**) erCaNAR2 (n = 15) (black curves), along with the red fluorescence intensity changes from RCaMP (red curves), in MIN6 cells stimulated with 20 mM TEA.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.004](10.7554/eLife.03765.004)10.7554/eLife.03765.005Figure 2---figure supplement 1.CaNAR expression levels do not affect subcellular calcineurin response dynamics.(**A**) Representative time-courses showing the TEA-stimulated response in MIN6 cells expressing high (1812), medium (521), or low (42) levels of cytoCaNAR2. (**B**) Representative time-courses showing the TEA-stimulated response in MIN6 cells expressing high (1441), medium (485), or low (158) levels of pmCaNAR2. (**C**) Representative time-courses showing the TEA-stimulated response in MIN6 cells expressing high (658), medium (384), or low (91) levels of mitoCaNAR2. (**D**) Representative time-courses showing the TEA-stimulated response in MIN6 cells expressing high (969), medium (599), or low (120) levels of erCaNAR2. Values in parentheses correspond to background-subtracted YFP intensities.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.005](10.7554/eLife.03765.005)

Using both cytosolic and plasma membrane-targeted CaNAR2, we were able to observe integrating, step-like patterns of calcineurin activity in response to TEA-induced Ca^2+^ oscillations, with each step-increase in calcineurin activity synchronized to a cytosolic Ca^2+^ peak, as measured by RCaMP ([Figure 2F,G](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}). We have seen previously that the FRET signal from CaNAR, which is based on calcineurin-dependent dephosphorylation of the N-terminal domain of nuclear-factor of activated T-cells (NFAT), is not easily reversed and can remain elevated even after cytosolic Ca^2+^ has returned to basal levels ([@bib65]). Indeed, these observations appear to confirm previous reports suggesting that calcineurin and NFAT behave as signal integrators to form a working memory of oscillatory Ca^2+^ signals, owing to the rapid dephosphorylation and slow rephosphorylation kinetics of NFAT family members ([@bib95]; [@bib20]). To our surprise, however, mitochondrial and ER-targeted CaNAR2 both exhibited far more reversible responses to cytosolic Ca^2+^ oscillations ([Figure 2H,I](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1D,E](#fig2s1){ref-type="fig"}). This difference was particularly striking for erCaNAR2, which exhibited almost perfect calcineurin activity oscillations upon TEA stimulation. Furthermore, these response patterns were independent of the CaNAR expression level ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), indicating that they reflect genuine differences in endogenous calcineurin signaling.

PKA opposes localized calcineurin signaling at the ER {#s2-2}
-----------------------------------------------------

Our findings suggest the existence of two discrete subcellular zones (e.g., cytosol/plasma membrane and ER/mitochondria) with distinct calcineurin signaling activities in MIN6 β-cells. We therefore investigated the molecular mechanisms responsible for defining these differential signaling zones. In particular, we focused on the reversibility of the CaNAR response at the ER surface, which suggested that calcineurin activity within this region of the cell is being precisely balanced by the action of endogenous kinases. A number of kinases have been shown to re-phosphorylate NFAT (reviewed in [@bib21]; [@bib44]) and are thus potentially capable of reversing the response from CaNAR. Notably, PKA phosphorylates multiple residues in NFAT ([@bib8]; [@bib84]), and PKA has repeatedly been shown to antagonize calcineurin signaling in the regulation of a variety of cellular processes such as exocytosis ([@bib50]), excitation-contraction coupling ([@bib81]), and mitochondrial division ([@bib22]). We therefore tested whether PKA activity is involved in reversing the ER-localized CaNAR response. In addition, we also tested the role of the Ca^2+^- and diacylglycerol-stimulated protein kinase (PKC), which may also phosphorylate NFAT ([@bib80]).

Blocking PKA activity by treating TEA-stimulated MIN6 cells with the PKA inhibitor H89 appeared to abolish erCaNAR2 oscillations, leading to a delayed but pronounced increase in the CaNAR response ([Figure 3A,B](#fig3){ref-type="fig"}). In addition, H89 treatment completely abolished the Ca^2+^ oscillations, which is consistent with the behavior of a previously described Ca^2+^/cAMP/PKA oscillatory circuit in MIN6 β-cells ([@bib67]). Curiously, the increased response from erCaNAR2 coincided with the attenuation of Ca^2+^ oscillations and the return of Ca^2+^ to basal levels. Despite the apparent lack of Ca^2+^ signaling, the observed increase in the erCaNAR2 response was nonetheless specifically caused by calcineurin activity, as the increase could be blocked by addition of the calcineurin inhibitor cyclosporin A prior to H89 treatment ([Figure 3E](#fig3){ref-type="fig"}). Moreover, addition of the PKC inhibitor Gö6983 to TEA-stimulated MIN6 cells also resulted in a steadily increasing erCaNAR2 response, accompanied by a transition from Ca^2+^ oscillations to persistently elevated cytosolic Ca^2+^ levels ([Figure 3C,D](#fig3){ref-type="fig"}).10.7554/eLife.03765.006Figure 3.Effect of PKA and PKC inhibition on TEA-induced ER calcineurin activity oscillations.(**A**) Representative time-course showing the effect of 20 μM H89 treatment on the TEA-stimulated responses from erCaNAR2 (black curve) and RCaMP (red curve) in MIN6 cells (n = 11). (**B**) Expanded time-course showing the TEA-stimulated responses from (**A**). (**C**) Representative time-course showing the effect of 10 μM Gö6983 on the TEA-stimulated responses from erCaNAR2 (black curves) and RCaMP (red curve) in MIN6 cells (n = 6). (**D**) Expanded time-course showing the TEA-stimulated responses from (**C**). (**E**) Representative time-course showing the responses from erCaNAR2 (black curve) and RCaMP (red curve) in MIN6 cells treated with 20 mM TEA, 6 μM cyclosporin A (CsA), and 20 μM H89 at the indicated times (n = 3).**DOI:** [http://dx.doi.org/10.7554/eLife.03765.006](10.7554/eLife.03765.006)

The fact that both inhibitor treatments altered the underlying Ca^2+^ dynamics prevented us from reaching any firm conclusions regarding the roles of PKA and PKC based on these experiments. We therefore sought an alternative method for generating repetitive Ca^2+^ spikes in MIN6 cells. TEA functions by blocking plasma membrane K^+^ channels, leading to membrane depolarization, and thereby activating voltage-gated Ca^2+^ channels ([@bib42]; [@bib103]). The direct addition of KCl also promotes depolarization-induced Ca^2+^ influx in electrically excitable cells such as β-cells ([@bib11]; [@bib74]; [@bib5]; [@bib35]; [@bib56]; [@bib29]), and repeated cycles of KCl addition and wash-out were successfully able to mimic TEA-stimulated oscillations in cytosolic Ca^2+^ levels and ER-localized calcineurin activity in MIN6 cells ([Figure 4A](#fig4){ref-type="fig"}).10.7554/eLife.03765.007Figure 4.PKA antagonizes ER calcineurin activity in MIN6 cells.(**A**) Manual induction of Ca^2+^ oscillations in MIN6 cells via repeated addition and washout of 15 mM KCl. Addition of KCl rapidly increases the responses from RCaMP (red curve) and erCaNAR2 (black curve), which are then both reversed upon washout. Repeating this process generates oscillatory responses. (**B**) Representative time-course showing the effect of 20 μM H89 treatment on the KCl-induced erCaNAR2 (black curve) and RCaMP (red curve) response in MIN6 cells (n = 5). H89 was added prior to the initial KCl treatment, and the H89 concentration in the experiment was maintained by re-addition of 20 μM H89 after washing out KCl. Although RCaMP did not detect Ca^2+^ responses in this experiment, Ca^2+^ spikes could clearly be seen using a high-affinity Ca^2+^ probe ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). (**C**) Representative time-course showing the effect of 10 μM Gö6983 treatment on the KCl-induced erCaNAR2 (black curve) and RCaMP (red curve) response in MIN6 cells (n = 4). Gö6983 was added prior to the initial KCl treatment, and the Gö6983 concentration in the experiment was maintained by re-addition of 10 μM Gö6983 after washing out KCl.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.007](10.7554/eLife.03765.007)10.7554/eLife.03765.008Figure 4---figure supplement 1.YC-Nano50 detects KCl-induced Ca^2+^ influx in the presence of H89.Representative curves showing the responses of both YC-Nano50 (black curves) and RCaMP (red curves) to repeated addition and wash-out of KCl in the (**A**) absence and (**B**) presence of 20 μM H89 treatment. H89 was added prior to the initial KCl treatment, and the H89 concentration in the experiment was maintained by re-addition of 20 μM H89 after washing out KCl. H89 abolishes the RCaMP response, whereas YC-Nano50 is still able to detect KCl-induced Ca^2+^ spikes.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.008](10.7554/eLife.03765.008)

Using this approach, we found that the addition of H89 resulted in an integrative, step-like response from erCaNAR2 ([Figure 4B](#fig4){ref-type="fig"}), much like that seen with cytoCaNAR2 in TEA-stimulated cells ([Figure 2F](#fig2){ref-type="fig"}), although RCaMP did not appear to respond under these conditions. However, we were able to confirm the generation of Ca^2+^ spikes using a higher affinity probe, YC-Nano50 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}; [@bib45]). In contrast to H89 treatment, the inclusion of Gö6983 to inhibit PKC activity did not appear to alter the response of erCaNAR2 to successive KCl treatments ([Figure 4C](#fig4){ref-type="fig"}). Here, the addition of the inhibitor resulted in an immediate increase in the erCaNAR2 FRET signal, though this was most likely due to non-specific increases in the background fluorescence due to the addition of Gö6983, which is fluorescent. Nevertheless, KCl-induced erCaNAR2 oscillations were still clearly observable above this increased background, as were the RCaMP Ca^2+^ spikes.

Our findings indicated that PKA activity, but not PKC activity, antagonizes calcineurin near the ER surface, thereby giving rise to ER-localized calcineurin activity oscillations in MIN6 cells. Based on these results, we tested whether differences in the level of PKA activity present in the cytosol and ER might contribute to differential calcineurin response patterns. To do so, we utilized variants of the FRET-based PKA activity reporter AKAR4 ([@bib25]) that were localized to the cytoplasm or ER via fusion to the targeting sequences described above ([Figure 5A](#fig5){ref-type="fig"}). We then compared the relative amounts of PKA activity in these two compartments by normalizing the TEA-stimulated PKA responses ([Figure 5C,D](#fig5){ref-type="fig"}) with respect to the total amount of PKA activity available in the cytosol and ER, which was defined as the maximum subcellular response observed upon combined treatment with the adenylyl cyclase activator forskolin (Fsk) and the general phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). Interestingly, we detected slightly less PKA activity at the ER, with TEA-stimulated AKAR4 responses reaching 55.4 ± 5.9% and 39.8 ± 3.3% (p = 0.0249) of the maximum dynamic range in the cytosol and at the ER, respectively ([Figure 5B](#fig5){ref-type="fig"}). We also found that setting PKA activity to maximum levels using IBMX pretreatment in conjunction with KCl stimulation, thus clamping PKA activity in these regions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), did not affect the subcellular CaNAR response patterns ([Figure 5E--H](#fig5){ref-type="fig"}).10.7554/eLife.03765.009Figure 5.Characterization of cytosolic and ER-localized PKA activity in MIN6 cells.(**A**) Schematic illustrating the domain structures of cyto- and erAKAR4. (**B**) Comparison of fractional PKA activity levels in the cytosol and ER of MIN6 cells. To determine the relative fraction of PKA activity being induced by TEA stimulation in each subcellular compartment, the FRET ratio change from each TEA-induced cytoAKAR4 or erAKAR4 response was divided by the maximum FRET ratio change observed upon co-stimulation with 50 μM Fsk and 100 μM IBMX. Data shown are presented as mean ± SEM, with n = 36 and 34 for cytoAKAR4 and erAKAR4, respectively. (**C** and **D**) Representative time-courses showing the responses from (**C**) cytoAKAR4 and (**D**) erAKAR4 (black curves), along with RCaMP (red curves), in MIN6 cells treated with 20 mM TEA. (**E-H**) Effect of maximal PKA activity on subcellular CaNAR2 responses. Representative time-courses showing the KCl-induced cytoCaNAR2 response in the (**E**) absence (n = 26) or (**G**) presence (n = 14) of 100 μM IBMX treatment in MIN6 cells, and representative time-courses showing the KCl-induced erCaNAR2 response in the (**F**) absence (n = 18) or (**H**) presence (n = 8) of 100 μM IBMX treatment in MIN6 cells. IBMX was added prior to the initial KCl treatment, and the IBMX concentration in the experiment was maintained by re-addition of 100 μM IBMX after washing out KCl.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.009](10.7554/eLife.03765.009)10.7554/eLife.03765.010Figure 5---figure supplement 1.Blocking oscillatory PKA activity in the cytosol and at the ER surface in MIN6 cells.(**A** and **B**) Representative time-courses showing the KCl-induced cytoAKAR4 response in the absence (**A**) or presence (**B**) of 100 μM IBMX treatment in MIN6 cells. (**C** and **D**) Representative time-courses showing the KCl-induced erCaNAR2 response in the absence (**C**) or presence (**C**) of 100 μM IBMX treatment in MIN6 cells. IBMX was added prior to the initial KCl treatment, and the IBMX concentration in the experiment was maintained by re-addition of 100 μM IBMX after washing out KCl.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.010](10.7554/eLife.03765.010)

Calcineurin activation kinetics are uniformly synchronized with cytosolic Ca^2+^ oscillations {#s2-3}
---------------------------------------------------------------------------------------------

Given that Ca^2+^ oscillations actually induce a lower amount of PKA activity at the ER surface compared with the cytosol, the apparent inability of PKA to reverse the cytosolic CaNAR response is puzzling. One possible explanation is that the kinetics of calcineurin activation itself may in fact differ in these two subcellular zones. Specifically, we reasoned that calcineurin may remain in an activated state for longer periods in the cytosol than at the ER surface in response to the individual Ca^2+^ pulses that occur during Ca^2+^ oscillations, thus potentially rendering cytosolic calcineurin activity less prone to the antagonistic effects of cytosolic PKA activity. To test this hypothesis, we took advantage of the intrinsic conformational changes that are associated with calcineurin activation.

Calcineurin exists as a stable heterodimer between a regulatory subunit (CNB) and a catalytic subunit (CNA) and becomes activated when Ca^2+^-bound CaM (Ca^2+^/CaM) binds to the regulatory arm of CNA, thus driving a conformational change that removes calcineurin from its basal, auto-inhibited state ([@bib79]; [@bib101]; [@bib78]). Guided by this information, we constructed a FRET-based reporter for monitoring calcineurin activation by sandwiching the catalytic subunit of calcineurin between Cerulean (i.e., CFP) and Venus (i.e., YFP) ([Figure 6A](#fig6){ref-type="fig"}). The resulting Calcineurin Activation Ratiometric indicator, or CaNARi, exhibited a robust increase in the cyan-to-yellow fluorescence emission ratio, which tracked closely with the increase in Ca^2+^ detected using RCaMP, in response to cytosolic Ca^2+^ elevation in HEK293 cells ([Figure 6B](#fig6){ref-type="fig"}). This Ca^2+^-induced FRET change could be blocked by pretreatment with the membrane-permeable CaM antagonist W7, indicating that the CaNARi response is in fact dependent on the binding of Ca^2+^/CaM ([Figure 6C](#fig6){ref-type="fig"}).10.7554/eLife.03765.011Figure 6.Development of CaNARi, a FRET-based reporter of calcineurin activation.(**A**) Schematic illustrating the domain structure of CaNARi and the proposed Ca^2+^/CaM-induced molecular switch. (**B**) Representative time-course showing the cyan/yellow (C/Y) emission ratio change from CaNARi (black curve), along with the RCaMP response (red curve), in HEK293 cells treated with 1 μM ionomycin (iono). (**C**) Summary of C/Y emission ratio responses from CaNARi in HEK293 cells stimulated using 1 μM iono with (+W7, n = 18) or without (−W7, n = 21) pretreating for 30 min with 50 μM of the CaM antagonist W7. Data shown are presented as mean ± SEM. \*p \< 0.0001.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.011](10.7554/eLife.03765.011)

We then tested whether the kinetics of calcineurin activation display subcellular variations in response to Ca^2+^ oscillations by localizing CaNARi to the cytosol and plasma membrane, as well as to the mitochondrial and ER surfaces, in MIN6 cells via fusion to the aforementioned targeting sequences ([Figure 7A](#fig7){ref-type="fig"}). As above, TEA stimulation induced cytosolic Ca^2+^ oscillations in the CaNARi-expressing MIN6 cells, as determined using co-expressed RCaMP. However, in contrast to the subcellular CaNAR responses, the responses from the targeted CaNARi variants were similar in all of the subcellular compartments that we examined ([Figure 7C--F](#fig7){ref-type="fig"}). Specifically, the responses from CaNARi in each subcellular region closely matched the cytosolic Ca^2+^ dynamics, rapidly increasing as Ca^2+^ levels rose and subsequently decreasing as Ca^2+^ fell back to basal levels, and revealed no major subcellular differences in how quickly calcineurin was turned on or off in response to oscillating Ca^2+^ levels. These results indicate that the kinetics of calcineurin activation are similar throughout the cell under these conditions.10.7554/eLife.03765.012Figure 7.Ca^2+^ oscillations induce uniform subcellular calcineurin activation patterns.(**A**) Schematic illustrating the domain structures of the subcellularly targeted CaNARi variants. (**B**) Summary of the C/Y emission ratio responses from each subcellularly targeted CaNARi variant. Data shown are presented as mean ± SEM, with n = 16, 13, 10, and 12 for cytoCaNARi, pmCaNARi, mitoCaNARi, and erCaNARi, respectively. (**C**--**F**) Representative time-courses showing the responses from (**C**) cytoCaNARi, (**D**) pmCaNARi, (**E**) mitoCaNARi, and (**F**) erCaNARi (black curves), along with the response from RCaMP (red curves), in MIN6 cells treated with 20 mM TEA.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.012](10.7554/eLife.03765.012)10.7554/eLife.03765.013Figure 7---figure supplement 1.Subcellular CaNARi responses are not affected by the reporter expression level.Scatter plots showing the maximum C/Y FRET ratio change vs YFP intensity (i.e., reporter expression level) for (**A**) cytoCaNARi, (**B**) pmCaNARi, (**C**) mitoCaNARi, and (**D**) erCaNARi. Weakly positive correlations were detected using linear regression analyses, though none were statistically significant.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.013](10.7554/eLife.03765.013)

Subcellular differences in Ca^2+^/CaM levels regulate calcineurin activity dynamics {#s2-4}
-----------------------------------------------------------------------------------

Although we were unable to observe any subcellular differences in the kinetics of calcineurin activation using CaNARi, our findings do not completely rule out a possible role for variations in subcellular calcineurin activation in regulating subcellular calcineurin activity. In fact, a closer inspection of the subcellularly targeted CaNARi responses revealed that both mitochondrial and ER-targeted CaNARi exhibited slightly smaller TEA-stimulated responses compared with the cytosolic and plasma membrane probes ([Figure 7B](#fig7){ref-type="fig"}). We also observed no correlation between the CaNARi response amplitude and the biosensor expression level ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), suggesting this difference was not an artifact of reporter expression. Although the trend was not statistically significant, these results lend credence to the hypothesis that different amounts of calcineurin are being activated in different parts of the cell.

We then investigated whether variations in upstream signaling components could be generating differences in subcellular calcineurin activation. Using subcellularly targeted versions of the green-fluorescent Ca^2+^ sensor GCaMP3 ([@bib94]), we were unable to detect any obvious differences in TEA-stimulated Ca^2+^ dynamics in the cytosol or at the ER surface with respect to the RCaMP response, although we did observe a steady rise in the basal Ca^2+^ level using ER-targeted GCaMP3 ([Figure 8](#fig8){ref-type="fig"}). These results largely agree with our subcellular CaNARi data and suggest that the divergent subcellular calcineurin activity patterns are not caused by local differences in the underlying Ca^2+^ dynamics (e.g., influx or efflux). In addition, only a small difference was observed when we compared the magnitude of these local Ca^2+^ signals, with a slightly lower amount of Ca^2+^ near the ER surface than in the cytosol (71.4% of max Ca^2+^ in the cytosol vs 61.2% at the ER, p = 0.0049).10.7554/eLife.03765.014Figure 8.Subcellular Ca^2+^ dynamics match global Ca^2+^ dynamics in MIN6 cells.Representative curves showing the response from (**A**) cytoGCaMP3 (n = 23) or (**B**) erGCaMP3 (n = 38) (green curves) and RCaMP (red curves) in MIN6 cells treated with 20 mM TEA. (**A**) To compare the Ca^2+^ dynamics in different subcellular compartments in MIN6 cells, GCaMP3 and RCaMP were first co-expressed in the cytosol. TEA stimulation induced completely overlapping responses from both probes, indicating that they have similar properties, though the RCaMP response amplitude often decreased over time. (**B**) GCaMP3 was then targeted to the ER surface while RCaMP was kept in the cytosol. Upon TEA stimulation, the GCaMP3 response again tracked closely with the RCaMP response, with no noticeable differences in the timing of Ca^2+^ increases or decreases between the ER and cytosol. The basal GCaMP response drifted upwards at the ER surface, but this did not affect the overall dynamics of the Ca^2+^ oscillations.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.014](10.7554/eLife.03765.014)

Calcineurin activation is also completely dependent on the binding of Ca^2+^/CaM, and multiple studies have shown that CaM is a limited cellular resource (reviewed in [@bib73]; [@bib83]). Indeed, the concentration of free CaM often reaches only 75 nM ([@bib73]; [@bib106]; [@bib83]), whereas CaM targets can be in excess of 20 μM ([@bib83]). Similarly, based on the kinetics of Ca^2+^ binding to and dissociation from the N- and C-lobes of CaM, it was calculated that Ca^2+^/CaM would only diffuse ∼0.1 μm before Ca^2+^ begins to dissociate, suggesting that Ca^2+^/CaM primarily acts as a highly localized signal ([@bib83]). Rapid, long-range signaling may even require actively transporting CaM to other parts of the cell ([@bib24]). Thus, taking into account both the scarcity of Ca^2+^/CaM and its limited range of action, along with the fact that calcineurin activity increases as a direct function of CaM concentration ([@bib75]), it is conceivable that even subtle variations in the availability of Ca^2+^/CaM could have a significant effect on local calcineurin activity ([Figure 9A](#fig9){ref-type="fig"}).10.7554/eLife.03765.015Figure 9.Subcellular Ca^2+^/CaM levels determine local calcineurin activity dynamics.(**A**) Model for the regulation of subcellular calcineurin activity in MIN6 cells by local variations in free Ca^2+^/CaM levels. As depicted in this illustration, CaM is predicted to be relatively abundant in the cytosol, thereby leading to strong activation of calcineurin (CaN) in the cytosol (red curve). Conversely, CaM is predicted to be present in much lower quantities near the ER surface, thereby leading to weaker levels of calcineurin activation at any given Ca^2+^ concentration in this part of the cell (green curve). (**B**) Summary of the C/Y emission ratio responses of BSCaM-2 expressed in the cytosol (Cyto) and at the ER surface without (ER) or with (ER+CaM) the overexpression of CaM in MIN6 cells. To achieve maximal levels of free Ca^2+^/CaM, cells were treated with 5 mM CaCl~2~ and 5 μM ionomycin. Data shown are presented as mean ± SEM, with n = 31, 33, and 34 for Cyto, ER, and ER+CaM, respectively. \*p \< 0.0001. (**C** and **D**) Representative time-courses showing the KCl-induced responses from erCaNAR2 in the (**C**) absence (n = 18) and (**D**) presence (n = 7) of CaM overexpression in MIN6 cells. (**E** and **F**) Representative time-courses showing the KCl-induced responses from cytoCaNAR2 in the (**E**) absence (n = 26) and (**F**) presence (n = 23) of 20 μM W7 treatment in MIN6 cells. W7 was added prior to the initial KCl treatment, and the W7 concentration in the experiment was maintained by re-addition of 20 μM W7 after washing out KCl.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.015](10.7554/eLife.03765.015)10.7554/eLife.03765.016Figure 9---figure supplement 1.Subcellular BSCaM-2 responses are not affected by the reporter expression level.Scatter plots showing the maximum C/Y FRET ratio change vs YFP intensity (i.e., reporter expression level) for (**A**) BSCaM-2, (**B**) erBSCaM-2, and (**C**) erBSCaM-2 + CaM, which correspond to 'Cyto', 'ER', and 'ER+CaM' in [Figure 9B](#fig9){ref-type="fig"}. Very weak positive or negative correlations were detected using linear regression analyses, though none of the correlations were statistically significant.**DOI:** [http://dx.doi.org/10.7554/eLife.03765.016](10.7554/eLife.03765.016)

To investigate subcellular differences in Ca^2+^/CaM levels, we used the FRET-based biosensor BSCaM-2, which has been used previously to measure free Ca^2+^/CaM levels in living cells ([@bib72]; [@bib96]), as well as to investigate subcellular differences in free Ca^2+^/CaM levels ([@bib92]). This reporter features a modified version of the Ca^2+^/CaM-binding sequence from avian smooth muscle myosin light chain kinase that binds Ca^2+^/CaM with a *K*~*d*~ of 2 nM. Calcineurin has been shown to bind Ca^2+^/CaM with sub-nanomolar affinity ([@bib46]; [@bib75]), therefore we reasoned that BSCaM-2 should offer a fair approximation of how much Ca^2+^/CaM is locally accessible by calcineurin. Our model predicts that free Ca^2+^/CaM is less abundant in the vicinity of the ER compared with the bulk cytosol ([Figure 9A](#fig9){ref-type="fig"}, left), and indeed we observed a significantly lower (p \< 0.0001) FRET response when BSCaM-2 was tethered to the ER surface than when it was able to diffuse freely through the cytosol ([Figure 9B](#fig9){ref-type="fig"}), suggesting that less Ca^2+^/CaM is present near the ER. These responses are similar to those observed by Teruel and colleagues, who reported smaller increases in free nuclear Ca^2+^/CaM levels compared with the cytosol in response to Ca^2+^ transients ([@bib92]). Our results also appear to reflect actual differences in subcellular Ca^2+^/CaM levels as opposed to Ca^2+^/CaM buffering, given that biosensor expression levels did not appear to affect the FRET responses ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}). More importantly, we found that overexpressing mCherry-tagged CaM was able to rescue most of the difference between the ER and cytosolic FRET responses ([Figure 9B](#fig9){ref-type="fig"}, 'ER+CaM').

Our model suggests that lower levels of Ca^2+^/CaM will result in weaker calcineurin activation near the ER surface ([Figure 9A](#fig9){ref-type="fig"}, red and green curves), which would in turn translate into lower levels of calcineurin activity that are more susceptible to antagonism by PKA activity. To test this model directly, we reasoned that if calcineurin activity is in fact being affected by local Ca^2+^/CaM levels, it should then be possible to generate cytosol-like CaNAR responses with erCaNAR2 by overexpressing CaM. Remarkably, combining mCherry-tagged CaM overexpression with the application of repeated, KCl-induced Ca^2+^ transients in CaNAR-expressing cells reveals that this is indeed the case. In contrast to cells expressing erCaNAR2 alone, which exhibit oscillatory FRET responses in response to repeated KCl stimulation and washout ([Figure 9C](#fig9){ref-type="fig"}), the co-expression of CaM-mCherry alongside erCaNAR2 clearly results in integrated calcineurin activity responses similar to those seen in the cytosol ([Figure 9D](#fig9){ref-type="fig"}). Conversely, reducing the amount of available Ca^2+^/CaM should lead to ER-like CaNAR oscillations in the cytosol. Indeed, pretreating cells with a low dose (20 μM) of the CaM antagonist W7 gave rise to oscillatory responses from cytoCaNAR2, in contrast to integrating responses in cells lacking W7 pretreatment ([Figure 9E,F](#fig9){ref-type="fig"}). Taken together, our results strongly suggest that free concentrations of Ca^2+^/CaM are limiting near the ER surface and thus significantly modulate the local, Ca^2+^ oscillation-induced calcineurin activity dynamics in this subcellular region.

Discussion {#s3}
==========

The spatiotemporal regulation of calcineurin signaling has come under increased scrutiny of late. Recently, calcineurin responses in cortical neurons treated with the amyloid-β peptide were shown to differ subcellularly, with more rapid calcineurin activation occurring in dendritic spines than in the cytosol and nucleus ([@bib105]). Calcineurin dynamics are also predicted to differ significantly within the dyadic cleft and cytosol in cardiomyocytes ([@bib82]). In keeping with these findings, our investigation revealed subcellular differences in the temporal pattern of calcineurin activity in response to Ca^2+^ oscillations in pancreatic β-cells. Specifically, cytosolic and plasma membrane calcineurin activity was observed to integrate Ca^2+^ oscillations, whereas Ca^2+^ oscillations evoked intermittent, oscillating calcineurin activity at the ER and mitochondria. Given the wide variety of cellular functions regulated by calcineurin signaling and the significant role of subcellular compartments in modulating signaling molecule behavior (see [@bib60]), this phenomenon is likely to shape calcineurin activity patterns in other cell types as well.

Our investigation into the spatiotemporal dynamics of calcineurin signaling turns on the use of a pair of FRET-based biosensors, each giving distinct responses based on its specific properties and thereby offering a multifaceted view of calcineurin behavior in living cells. The CaNAR family, including CaNAR2 and its precursor CaNAR1 ([@bib65]), utilizes the well-characterized dephosphorylation of NFAT to report on the substrate-level dynamics of calcineurin activity and is sensitive to multiple cellular factors, such as both phosphatase and kinase activity. We also generated CaNARi, which reports on the activation of calcineurin upon the binding of Ca^2+^/CaM. The CaNARi response is exclusively determined by the intrinsic affinities between Ca^2+^, CaM, and calcineurin, and CaNARi revealed largely uniform subcellular calcineurin activation patterns during Ca^2+^ oscillations. On the other hand, CaNAR was able to detect clear subcellular variations in calcineurin activity, which stems from the fact that CaNAR monitors the net endogenous calcineurin activity at each location. The enzymatic nature of CaNAR, wherein calcineurin dephosphorylates many probe molecules, also makes it more sensitive for detecting weak calcineurin signals. However, given the somewhat peculiar dephosphorylation and rephosphorylation behavior of NFAT ([@bib68]; [@bib95]), CaNAR may not reflect calcineurin activity towards all targets. Additional approaches, including redesigned CaNARs, are therefore needed to provide a more complete picture.

The differential calcineurin activity dynamics suggest that different cellular compartments are tuned for regulating distinct calcineurin targets. For example, mice specifically lacking calcineurin in β-cells show impaired insulin production and decreased expression of several critical genes, all of which are regulated by the calcineurin-dependent transcription factor NFAT ([@bib39]). The efficient activation and nuclear translocation of NFAT in response to Ca^2+^ oscillations requires periods of sustained calcineurin activity to produce a cytoplasmic pool of dephosphorylated NFAT that is available for nuclear import ([@bib95]). Correspondingly, the sustained, integrating calcineurin activity patterns we observed in the cytosolic and plasma membrane regions of MIN6 cells indicated that this signaling domain is optimized for the oscillatory control of transcriptional regulation. In fact, the plasma membrane may play a particularly crucial role in promoting calcineurin/NFAT signaling. The scaffolding protein AKAP79/150 has specifically been shown to recruit calcineurin into a signaling complex located at the C-terminus of the L-type voltage-gated Ca^2+^ channel (VGCC) in hippocampal neurons ([@bib69]), and the presence of anchored calcineurin within this complex was required for proper NFAT-dependent nuclear signaling in these cells ([@bib69]; [@bib52]). Both Ca^2+^ influx through the L-type VGCC and AKAP anchoring of calcineurin are also important for insulin secretion ([@bib12]; [@bib104]; [@bib7]; [@bib50]; [@bib43]), therefore it is possible that an AKAP-calcineurin-VGCC complex is similarly involved in calcineurin/NFAT signaling in β-cells.

In contrast to the cytosol and plasma membrane, however, the oscillatory calcineurin activity we observed near the ER and mitochondria in MIN6 cells suggests weak and intermittent NFAT activation ([@bib95]). As such, transcriptional signaling via NFAT is likely not the primary function of calcineurin in these subcellular regions. Our previous findings indicate that oscillatory signals can spatially restrict enzyme activity ([@bib67]); thus, calcineurin activity oscillations may alternatively be directed towards local ER and mitochondrial targets. For instance, calcineurin was recently shown to dephosphorylate the Ca^2+^-dependent chaperone calnexin and interact with the ER kinase PERK to modulate protein folding and ER stress ([@bib13]), while calcineurin and PERK also jointly regulate insulin secretion ([@bib102]). Similarly, calcineurin dephosphorylates and activates the mitochondrial fission protein Drp1 ([@bib22]; [@bib17], [@bib16]; [@bib86]). Interestingly, Drp1-mediated mitochondrial division involves direct contact between the outer mitochondrial membrane and ER tubules ([@bib30]). It is conceivable that such contact points are hotspots for local calcineurin signaling; the ER and mitochondria are in fact characterized by extensive physical and functional coupling (reviewed in [@bib23]; [@bib77]).

Further analyses revealed that PKA, which opposes calcineurin activity towards Drp1 ([@bib22]), antagonizes calcineurin at the ER and helps give rise to calcineurin activity oscillations. Curiously, inhibiting PKA in TEA-stimulated MIN6 cells led to steadily increasing ER calcineurin activity, despite cytosolic Ca^2+^ apparently returning to basal levels. This effect was blocked by calcineurin inhibition and may be due to residual activity from ER Ca^2+^ release channels or to passive Ca^2+^ leak from the ER ([@bib14]; [@bib89]; [@bib36]). However, PKA activity was not sufficient to produce calcineurin activity oscillations, as even saturating amounts of PKA activity did not lead to CaNAR oscillations in the cytosol. AKAPs may be involved in locally promoting the PKA-mediated antagonism of calcineurin signaling, and DAKAP1 (AKAP121), which binds calcineurin ([@bib1]), in fact targets to both the mitochondrial and ER membranes ([@bib55]). AKAP79 is also known to anchor PKA and calcineurin to the plasma membrane in β-cells ([@bib50]), yet calcineurin responses nevertheless appear integrative in this region. We also detected less free Ca^2+^/CaM near the ER surface compared with the cytosol, and CaM overexpression led to integrating rather than oscillating ER calcineurin activity, whereas inhibiting CaM produced the opposite effect in the cytosol. Both of these results are consistent with a model in which limited access to CaM at the ER leads to weak calcineurin activity. Since excess calcineurin activity can lead to β-cell dysfunction and death ([@bib9]), often involving ER stress and apoptosis, this combination of PKA activity and limited access to CaM may help constrain local calcineurin signals within physiologically permissible limits.

Our results clearly show that the distribution of CaM directly determines subcellular calcineurin activity during β-cell Ca^2+^ oscillations. CaM acts as both a dedicated regulatory subunit and a promiscuous binding partner depending on the specific target ([@bib83]), and whereas promiscuous CaM is free to associate with and dissociate from target proteins as a function of Ca^2+^, dedicated CaM remains bound irrespective of changes in the Ca^2+^ concentration. Subcellular variations in the amounts of dedicated CaM targets may therefore affect the levels of promiscuous CaM that can activate calcineurin in response to Ca^2+^ signals. Moreover, the Ca^2+^-binding kinetics of CaM limit its range of action and potentially require CaM to be activated within Ca^2+^ microdomains ([@bib83]). In β-cells, Ca^2+^ oscillations are often driven by VGCCs in the plasma membrane ([@bib4]; [@bib40]; [@bib12]; [@bib59]; [@bib91]), and CaM has been found to be locally enriched near these channels ([@bib62]), ready to be activated by local Ca^2+^. AKAP79 has also been shown to bind CaM ([@bib34]), thereby serving as another potential source for local Ca^2+^/CaM and also perhaps lowering the ability of anchored PKA to antagonize local calcineurin activity. However, additional studies are needed to unravel the precise mechanisms underlying the spatial differences in CaM levels.

In neurons and cardiomyocytes, calcineurin is implicated to behave as an integrator or peak number counter in response to Ca^2+^ oscillations ([@bib82]; [@bib87]; [@bib53]; [@bib31]). In these cells, rapid (i.e., \> 1 s^−1^) Ca^2+^ transients, combined with the slow dissociation of calcineurin and Ca^2+^/CaM, facilitate persistent calcineurin activation ([@bib87]). This also engenders the preferential activation of calcineurin at lower oscillatory frequencies compared with other targets (e.g., CaMKII), resulting in frequency decoding. In β-cells, on the other hand, Ca^2+^ oscillations are slow (i.e., \< 1 min^−1^) ([@bib40]; [@bib91]), and our results indicate that Ca^2+^/CaM fully dissociates from calcineurin in between each Ca^2+^ peak, suggesting that frequency modulation may not be a prominent feature in β-cell calcineurin signaling. Rather, we found that CaM plays a critical role in spatial signaling under these conditions, which has been hinted at previously ([@bib92]). Furthermore, the frequency decoding observed in neurons and cardiomyocytes is based entirely on the intrinsic kinetics of CaM-target interactions where CaM plays a passive role. Conversely, our analyses highlight a novel mechanism whereby cells utilize CaM to actively encode spatial information, which is then decoded by calcineurin to ensure that oscillatory Ca^2+^ signals are transduced properly within specific local contexts.

Materials and methods {#s4}
=====================

CaNAR2 construction {#s4-1}
-------------------

Each CaNAR variant was generated by sandwiching the substrate domain of CaNAR1, which corresponds to amino acids 1--297 from the N-terminus of NFAT1 ([@bib65]), between different cyan (CFP) and yellow fluorescent protein (YFP) variants. Cerulean ([@bib76]), Cerulean2, Cerulean3 ([@bib58]), circularly permuted Venus (E172) ([@bib63]), and YPet ([@bib66]) were each subcloned using *Bam*HI and *Sph*I restriction sites (for CFP) or *Sac*I and *Eco*RI restrictions sites (for YFP) to replace the original ECFP or circularly permuted Venus (L194) in CaNAR1. All CaNAR constructs were generated in the pRSETB vector (Invitrogen, Carlsbad, CA) and then subcloned into pCDNA3 (Invitrogen) for subsequent mammalian expression. Plasma membrane-, outer mitochondrial membrane-, and ER-targeted CaNAR2 constructs were generated by in-frame fusion of full-length CaNAR2 with the N-terminal 11 amino acids from Lyn kinase, the N-terminal 30 amino acids from DAKAP1, and the N-terminal 27 amino acids from CYP450, respectively. Similarly, cytosolic CaNAR2 was generated by in-frame fusion of a C-terminal NES (LPPLERLTL) immediately prior to the stop codon. All constructs were verified by sequencing.

CaNARi construction {#s4-2}
-------------------

CaNARi was generated in pCDNA3.1(+) (Invitrogen). The full-length α isoform of CNA was PCR amplified from pETCNα ([@bib61]), a gift of Fan Pan (Johns Hopkins School of Medicine, Baltimore, MD), using primers incorporating a 5′ *Bam*HI site and 3′ *Xho*I site. Cerulean was PCR amplified from plasmid DNA using a forward primer encoding a 5′ *Hind*III restriction site followed by a Kozak consensus sequence for mammalian expression ([@bib47]) and a reverse primer encoding a 3′ *Bam*HI site. Similarly, Venus was PCR amplified from plasmid DNA using primers encoding a 5′*Xho*I site and 3′ *Xba*I site. The resulting PCR fragments were digested with the corresponding restriction enzymes, gel purified, and ligated into pCDNA3.1(+). To generate the plasma membrane-, outer mitochondrial membrane-, and ER-targeted CaNARi constructs, Cerulean was PCR amplified from plasmid DNA using nested forward primers encoding a 5′ *Hind*III site, a Kozak translation initiation sequence, and the N-terminal targeting sequence from either Lyn kinase, DAKAP1, or CYP450, along with a reverse primer encoding a 3′ *Bam*HI site. The PCR fragments were then subcloned into CaNARi in pCDNA3.1(+) using *Hind*III and *Bam*HI to replace the original Cerulean sequence. Similarly, cytosol-targeted CaNARi was generated by PCR amplification of Venus using a forward primer encoding a 5′ *Xho*I site and nested reverse primers encoding a 3′ *Xba*I site and an NES. The PCR fragment was subcloned into CaNARi in pCDNA3.1(+) using *Xho*I and *Xba*I to replace the original Venus sequence. All constructs were verified by sequencing.

Other plasmids {#s4-3}
--------------

ER-targeted AKAR4 was generated from AKAR4 ([@bib25]) as above. The Ca^2+^/CaM biosensor BSCaM-2 ([@bib72]; [@bib96]) was a gift of Dr Anthony Persechini (University of Missouri--Kansas City, Kansas City, MO). ER-targeted BSCaM-2 was generated by subcloning full-length BSCaM-2 between the *Hind*III and *Xba*I sites of pCDNA3.1(+) containing the N-terminal targeting sequence from CYP450. The CaM-mCherry construct was generated by PCR amplification of full-length CaM (without a stop codon) from plasmid DNA using primers encoding a 5′ *Nhe*I site and a 3′ *Bam*HI site and PCR amplification of mCherry (with a stop codon) from plasmid DNA using primers encoding a 5′ *Bam*HI site and 3′ *Eco*RI site. The resulting PCR fragments were digested using the corresponding restriction enzymes, gel purified, and ligated into pCDNA3.1(+). The red-fluorescent Ca^2+^ sensor RCaMP ([@bib2]) and the green-fluorescent Ca^2+^ sensor GCaMP3 ([@bib94]) were kind gifts of Dr Loren Looger (Janelia Farm Research Campus, HHMI, Ashburn, VA). Subcellularly targeted versions of GCaMP3 were generated by PCR amplification of GCaMP3 (with or without a stop codon) using primers encoding a 5′ *BamH*I site and a 3′ *EcoR*I site and subcloning into a plasmid containing either an NES or an ER-targeting sequence as above. The high affinity FRET-based Ca^2+^ sensor YC-Nano50 ([@bib45]) was provided Dr Takeharu Nagai (Hokkaido University, Sapporo, Hokkaido, Japan). All constructs were verified by sequencing.

Cell culture and transfection {#s4-4}
-----------------------------

HEK293 cells were cultured in Dulbecco modified Eagle medium (DMEM; Gibco, Grand Island, NY) containing 1 g/l glucose and supplemented with 10% (vol/vol) fetal bovine serum (FBS, Sigma, St. Louis, MO) and 1% (vol/vol) penicillin-streptomycin (Pen-Strep, Sigma-Aldrich, St. Louis, MO). MIN6 β-cells were cultured in DMEM containing 4.5 g/l glucose and supplemented with 10% (vol/vol) FBS, 1% (vol/vol) Pen-Strep, and 50 μM β-mercaptoethanol. All cells were maintained in a humidified incubator at 37°C with a 5% CO~2~ atmosphere. Prior to transfection, cells were plated onto sterile, 35-mm glass-bottomed dishes and grown to 50--70% confluence. Cells were then transfected using calcium phosphate and grown an additional 24--48 hr (HEK) or using Lipofectamine 2000 (Invitrogen) and grown an additional 48--96 hr (MIN6) before imaging.

Reporter localization {#s4-5}
---------------------

MIN6 β-cells expressing either mitochondrial or ER-targeted CaNAR2 were stained for 30 min with MitoTracker RED (Molecular Probes, Eugene, OR) or ER-Tracker RED (Molecular Probes), respectively, at a final concentration of 1 μM in Hank's Balanced Salt Solution (HBSS). These cells, as well as cells expressing cytosolic or plasma membrane-targeted CaNAR2, were imaged on a Nikon Eclipse Ti inverted fluorescence microscope (Nikon Instruments, Melville, NY) equipped with a perfect focus system (Nikon), a 100x/1.49 NA oil-immersion objective lens, an electron multiplying charge coupled device camera (Photometrics, Tucson, AZ), and a laser TIRF system (Nikon). YFP and RFP images were acquired using a 514-nm argon laser (Melles Griot, Rochester, NY) and a 561-nm Sapphire solid-state laser (Coherent, Santa Clara, CA), respectively. The system was controlled using the NIS-Elements software package (Nikon). Exposure times were between 50 and 200 ms. Images were analyzed using ImageJ software (<http://imagej.nih.gov/ij/>).

FRET imaging {#s4-6}
------------

Cells were washed twice with HBSS and subsequently imaged in the dark at 37°C. Tetraethylammonium chloride (TEA; Sigma), thapsigargin (TG; Sigma), ionomycin (iono; Calbiochem, San Diego, CA), calcium chloride (CaCl~2~; Sigma), W-7 (Cayman Chemical, Ann Arbor, MI), potassium chloride (KCl; JT Baker, Phillipsburg, NJ), H89 (Sigma), Gö6983 (Sigma), forskolin (Fsk; Calbiochem), and 3-isobutyl-1-methylxanthine (IBMX; Sigma) were added as indicated. Images were acquired using an Axiovert 200M inverted fluorescence microscope (Carl Zeiss, Thornwood, NY) with a 40x/1.3 NA oil-immersion objective lens and a cooled charge-coupled device camera (Roper Scientific, Trenton, NJ) controlled by Metafluor 7.7 software (Molecular Devices, Sunnyvale, CA). Dual cyan/yellow emission ratio imaging was performed using a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission filters (475DF40 for CFP and 535DF25 for YFP). RFP intensity was imaged using a 568DF55 excitation filter, a 600DRLP dichroic mirror, and a 653DF95 emission filter. Filter sets were alternated using a Lambda 10--2 filter changer (Sutter Instruments, Novato, CA). Exposure times were between 10 and 500 ms, and images were taken every 20--30 s. Raw fluorescence images were corrected by subtracting the background fluorescence intensity of a cell-free region from the emission intensities of biosensor-expressing cells. Emission ratios (yellow/cyan or cyan/yellow) were then calculated at each time point. All time-courses were normalized by dividing the emission ratio or, in the case of RCaMP, the intensity at each time point by the basal value immediately preceding drug addition.
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\[Editors' note: an earlier version of this submission was rejected after peer review but the authors submitted for further consideration.\]

Thank you for choosing to send your work entitled "Calmodulin-controlled spatial decoding of oscillatory Ca^2+^ signals by calcineurin" for consideration at *eLife*. Your full submission has been evaluated by a Senior editor and 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the decision was reached after discussions between the reviewers. We regret to inform you that your work will not be considered further for publication at this time.

The research is novel, with sophisticated use of FRET reporters. The finding that calcineurin activity is restricted in the vicinity of the ER/mitochondria is interesting and unexpected. However, there were a number of substantive concerns raised by the reviewers that mean that substantial revision, including new experiments, would be required before further consideration. These concerns are detailed below. Regrettably, *eLife* policy is to reject papers requiring major revisions.

*Reviewer 1*:

The authors show that NFAT phosphorylation state integrates calcium waves in the cytosol but oscillates with calcium waves at the ER (measured with a calmodulin reporter). Oscillation is expected if each wave of calcium-dependent dephosphorylation (by calcineurin) is fully reversed (by PKA) during the ensuing low calcium period, while integration is expected if reversal is incomplete. Differential NFAT phosphorylation kinetics might be explained if PKA were less active in the cytosol than ER. However, the authors found that PKA activity oscillations are of similar magnitude at the ER and cytosol, so this explanation is unlikely. Alternatively, less calcineurin may be activated near the ER, so it may be more readily antagonized by PKA. Calmodulin is known to be much less abundant than its effectors. To test whether calmodulin is limiting for calcineurin activation near the ER, they over-expressed calmodulin and found that this switched ER calcineurin activity from oscillating to integrating modes. Based on this, the authors conclude that calmodulin competition explains the observations. Another finding is that, even though NFAT phosphorylation kinetics are different in cytosol and at ER, calcineurin conformation changes, which require calcium-calmodulin, oscillate in both localizations.

1\) Given that calmodulin is limiting, over-expressing calmodulin-binding reporters will likely upset the normal balance. How does CaNAR2 level compare with endogenous NFAT? If CaNAR2 is more highly expressed at ER than cytosol, that could explain the difference. Similarly, the conformation detector, CaNARi, could be expressed at lower level. Expression levels need to be measured and confirmed to be equivalent.

2\) Roles for calcium stores in the ER should be excluded, e.g, using appropriate drugs.

3\) The co-oscillation of PKA and calcium is not unexpected, but hinders clear interpretation of the data. The results would be more compelling if PKA activity was buffered to prevent oscillation.

4\) Effect of over-expressing calmodulin should be complemented by inhibiting calmodulin. Low doses of W7 or calmodulin siRNA should cause oscillations of NFAT phosphorylation in the cytosol as well as the ER.

5\) It is not clear from the model why the calcineurin conformation sensor oscillates at the ER. The magnitude of FRET oscillation is similar at ER and cytosol in the traces shown. If calmodulin were limiting, less magnitude would be expected. The explanation is unclear and needs to be resolved.

*Reviewer 2*:

The work of Zhang et al attempts to analyze spatial differences in calcium oscillation profiles with intact beta cells. The authors chose pancreatic beta cells likely because of their known ability to produce massive calcium oscillations, although the connection to insulin secretion was not investigated in this work. The authors employ improved and locally acting sensors (CaNAR2 and CaNARi) to measure calcineurin activity, BSCaM-2 to sense Ca/CaM levels, and an intensiometric genetically encoded calcium sensor. One of the major findings in the present work is that calcineurin oscillations distant from ER membranes are less dynamic (\'integrating\') than those close to the ER.

1\) I don\'t understand why the mitochondria region differs from the cytosol response.

2\) I also wonder if the calcium oscillations close to the plasma or the ER membrane, respectively, differ in a similar way as the calcineurin responses. Strong support comes from experiments where CaM is overexpressed and the ER-located sensor mimics the cytosol and plasma membrane location. What is missing is the alternative experiment, where calcineurin should be blocked by modest levels of W-7. This should lead to perfect oscillations of calcineurin everywhere.

The difference in the oscillation patterns could also be driven by activities in the respective membranes such as calcium influx close to the plasma membrane or more efficient calcium uptake by SERCA close to the ER. These possibilities have not been investigated and are not discussed.

3\) Similarly, effects of the PKA and PKC inhibitors might strongly influence calcium channels including the IP3 receptor and might therefore change the threshold calcium level required for successful oscillations. The hypothesis that there is calcium leakage close to the ER is a weak explanation for the steady increase in calcineurin activity after Goe6983 and H89.

4\) The model presented is based on the fact that Ca/CaM activates calcineurin. However, it was previously shown that activation of non-calcium-dependent phosphatases such as PP1 suffice to induce calcium oscillations in the absence of depolarization, likely by changing the phosphorylation level of the IP3 receptor (Reither et al., 2013). Is calcineurin activation also inducing calcium signals? If this were the case, the model would need to be much more complicated.

5\) I trust the statement that CaM might be scarce in some cells but how abundant is it in Min6 cells? At least an estimate from the transcriptome should have been provided as the conclusion on subcellular differences in Ca/CaM is based on the scarcity assumption. Further, if the CaM concentration were indeed in the sub 100 nM range, then overexpression of a CaM binding protein (usually in the micromolar range) will definitely buffer CaM close to its location on the ER membrane. There is a chance that either there is enough CaM or if not that the sensor produces an artifact. I fear the authors can\'t win on this one. Was BSCaM-2 also attached to the plasma membrane and used to determine the CaM concentration there?

In conclusion, although very interesting, there are too many open questions and too many experiments that needed to be done to accept this paper.

10.7554/eLife.03765.018

Author response

A number of changes, including several new experiments, have been incorporated into the new submission, and we believe that these changes fully address the concerns raised by the reviewers.

Reviewer 1:

*1) Given that calmodulin is limiting, over-expressing calmodulin-binding reporters will likely upset the normal balance. How does CaNAR2 level compare with endogenous NFAT? If CaNAR2 is more highly expressed at ER than cytosol, that could explain the difference. Similarly, the conformation detector, CaNARi, could be expressed at lower level. Expression levels need to be measured and confirmed to be equivalent*.

The reviewer raises an important point regarding the biosensor expression levels. Unfortunately, after searching the literature and consulting with outside experts, we were unable to find any concrete data on the endogenous expression levels of the various NFAT isoforms. Nevertheless, we used purified YFP to calibrate the intensity counts generated on our microscope, and based on this calibration, we were able to estimate that the intracellular concentration of cytoCaNAR2 ranged between approximately 45 nM and 4 μM in our experiments. Importantly, we also found that the response patterns reported by each subcellularly targeted CaNAR2 variant held steady over similar ranges of biosensor expression levels, and the Results section has been updated to reflect this finding (see [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}). Similarly, we found no meaningful correlation between the expression levels of the calcineurin conformation sensor (CaNARi) or the Ca^2+^/CaM probe (BSCaM-2) and their observed FRET ratio changes. Based on these data, we conclude that biosensor expression did not influence our reported observations.

*2) Roles for calcium stores in the ER should be excluded, e.g. using appropriate drugs*.

We investigated this using subcellularly targeted versions of GCaMP3 co-transfected along with diffusible RCaMP, and we observed no differences between local Ca^2+^ dynamics in the cytosol, at the ER surface, or even at the plasma membrane compared with global Ca^2+^ dynamics. The ER and cytosol data have been added to the revised manuscript. Furthermore, although ER-targeted GCaMP3 showed that basal Ca^2+^ levels near the ER drift upwards during oscillations, this basal drift does not impact the erCaNAR response, suggesting that ER stores are not playing a significant role in the differential calcineurin activities. We did detect a minor difference in the Ca^2+^ amplitude at the ER surface versus the cytosol, and the manuscript has been updated to reflect this observation; however, the fact that altering calmodulin alone, either via overexpression or by W7 inhibition, can change the calcineurin activity patterns points to a more direct role for calmodulin.

*3) The co-oscillation of PKA and calcium is not unexpected, but hinders clear interpretation of the data. The results would be more compelling if PKA activity was buffered to prevent oscillation*.

As suggested by the reviewer, we have updated [Figure 5](#fig5){ref-type="fig"} with experiments in which the PKA activity was clamped at a steady level. To do so, we pretreated cells with the pan-phosphodiesterase inhibitor IBMX, which led to maximal PKA activity, and then treated these cells with repeated doses of KCl followed by wash out. We observed no differences in the CaNAR response patterns under these conditions compared with conditions in which PKA activity was allowed to oscillate -- i.e., cytoCaNAR2 had an integrating response and erCaNAR2 had an oscillating response.

*4) Effect of over-expressing calmodulin should be complemented by inhibiting calmodulin. Low doses of W7 or calmodulin siRNA should cause oscillations of NFAT phosphorylation in the cytosol as well as the ER*.

We thank the reviewer for suggesting this experiment. We indeed found that pretreating MIN6 cells with a submaximal dose (20 μM) of W7, followed by repeated doses of KCl, produces completely oscillatory responses from cytoCaNAR2. This new data has been added to [Figure 9](#fig9){ref-type="fig"} in the revised manuscript.

*5) It is not clear from the model why the calcineurin conformation sensor oscillates at the ER. The magnitude of FRET oscillation is similar at ER and cytosol in the traces shown. If calmodulin were limiting, less magnitude would be expected. The explanation is unclear and needs to be resolved*.

Given that the activation, and hence the conformation, of calcineurin is strictly controlled by cytosolic Ca^2+^ elevations, Ca^2+^ oscillations are still expected to induce oscillatory calcineurin activation even if less calcineurin is being activated. In addition, because the FRET response from this sensor is small, it may not be able to reliably report differences in calcineurin activation amplitude. Nevertheless, based on this comment, we compared the response amplitudes more closely and found that the responses from mitochondrial and ER-targeted CaNARi were in fact smaller on average than those from cytosolic and plasma membrane CaNARi. These data are now summarized in [Figure 7B](#fig7){ref-type="fig"} of the revised manuscript. Although the difference was not statistically significant, the observed trend supports our model, and we thank the reviewer for prompting this closer look at our data.

Reviewer 2:

*1) I don\'t understand why the mitochondria region differs from the cytosol response*.

We have chosen to focus on the different activity dynamics between the ER surface and the cytosol. The activity dynamics on the outer mitochondrial membrane were similar to what was observed at the ER, and the underlying mechanism(s) will be examined in future studies.

*2) I also wonder if the calcium oscillations close to the plasma or the ER membrane, respectively, differ in a similar way as the calcineurin responses. Strong support comes from experiments where CaM is overexpressed and the ER-located sensor mimics the cytosol and plasma membrane location. What is missing is the alternative experiment, where calcineurin should be blocked by modest levels of W-7. This should lead to perfect oscillations of calcineurin everywhere*.

*The difference in the oscillation patterns could also be driven by activities in the respective membranes such as calcium influx close to the plasma membrane or more efficient calcium uptake by SERCA close to the ER. These possibilities have not been investigated and are not discussed*.

As mentioned above in response to reviewer 1, we observed no differences between the Ca^2+^ oscillations in the cytosol, at the ER surface, or at the plasma membrane (measured using subcellularly targeted GCaMP3) and global Ca^2+^ oscillations (measured concurrently using diffusible RCaMP), suggesting that local Ca^2+^ signals are not the determining factor for the differential calcineurin responses. The GCaMP/RCaMP curves for the cytosol and ER have been added to the revised manuscript ([Figure 8](#fig8){ref-type="fig"}).

We thank the reviewer for suggesting this experiment. As mentioned above, we indeed found that pretreating MIN6 cells with a submaximal dose (20 μM) of W7, followed by repeatedly adding and washing out KCl, produces completely oscillatory responses from cytoCaNAR2. These new data have been added to [Figure 9](#fig9){ref-type="fig"} in the revised manuscript.

*3) Similarly, effects of the PKA and PKC inhibitors might strongly influence calcium channels including the IP3 receptor and might therefore change the threshold calcium level required for successful oscillations. The hypothesis that there is calcium leakage close to the ER is a weak explanation for the steady increase in calcineurin activity after Goe6983 and H89*.

The reviewer is correct that the inhibition of PKA or PKC could alter the behavior of Ca^2+^ channels. For example, PKA has been shown to stimulate the activity of both the L-type VGCC and the IP3 receptor; thus, inhibiting PKA should lead to decreased Ca^2+^ influx, which is in fact what we observe in [Figure 3A](#fig3){ref-type="fig"}. Conversely, PKC has been shown to inhibit both of these channels, and we also see in [Figure 3C](#fig3){ref-type="fig"} that inhibiting PKC leads to increased Ca^2+^ levels and, potentially, increased calcineurin activity (see responses to reviewer 1 above). Whereas the increase in calcineurin activity after PKC inhibition is clearly due to the elevated Ca^2+^, we attributed the increased calcineurin activity after PKA inhibition to Ca^2+^ leak because of the decreased Ca^2+^ level and the likely decrease in IP3R-mediated Ca^2+^ release, though the latter may still be having an effect.

*4) The model presented is based on the fact that Ca/CaM activates calcineurin. However, it was previously shown that activation of non-calcium-dependent phosphatases such as PP1 suffice to induce calcium oscillations in the absence of depolarization, likely by changing the phosphorylation level of the IP3 receptor (Reither et al., 2013). Is calcineurin activation also inducing calcium signals? If this were the case, the model would need to be much more complicated*.

Calcineurin has been shown to interact with ER Ca^2+^ release channels, such as the IP3 receptor, and may potentially modulate their activity, though this remains somewhat controversial. In addition, calcineurin is known to inhibit influx through plasma membrane Ca^2+^ channels. Therefore, it is more likely that calcineurin is modulating existing Ca^2+^ signals rather than inducing them per se. It is possible that calcineurin exerts other effects to stimulate Ca^2+^ influx; however, there is currently no firm evidence that would lead us to pursue this direction.

*5) I trust the statement that CaM might be scarce in some cells but how abundant is it in Min6 cells? At least an estimate from the transcriptome should have been provided as the conclusion on subcellular differences in Ca/CaM is based on the scarcity assumption. Further, if the CaM concentration were indeed in the sub 100 nM range, then overexpression of a CaM binding protein (usually in the micromolar range) will definitely buffer CaM close to its location on the ER membrane. There is a chance that either there is enough CaM or if not that the sensor produces an artifact. I fear the authors can\'t win on this one. Was BSCaM-2 also attached to the plasma membrane and used to determine the CaM concentration there? In conclusion, although very interesting, there are too many open questions and too many experiments that needed to be done to accept this paper*.

We have not used this BSCaM-2-based approach to determine free Ca^2+^/CaM concentrations; rather, our aim was simply to compare the relative Ca^2+^/CaM levels in different compartments, as has been previously done using these probes ([@bib92]). To our knowledge, this type of information is difficult to obtain using other methods. Both cytosolic and plasma membrane-targeted BSCaM-2 showed identical responses (80.61 ± 0.03% vs. 79.15 ± 0.04% FRET ratio change), whereas the response at the ER surface is lower (50.74 ± 0.03%), suggesting that the free Ca^2+^/CaM level is lower in this compartment. No downstream signaling processes were monitored in the BSCaM-2 experiments, thereby limiting the potential for buffering effects, and we also found no correlation between probe expression and the FRET response over a large range of expression levels, which we would have expected to see were the biosensor levels impacting the results. Furthermore, overexpressing CaM or inhibiting CaM using W7 clearly modulated the ER and cytosolic CaNAR responses, respectively, not to mention the fact that overexpressing CaM rescued the BSCaM-2 response at the ER surface (70.03 ± 0.03%). These observations in particular strongly suggest that free Ca^2+^/CaM levels are limiting near the ER surface, resulting in weaker calcineurin activation at this location. Similar observations were made by Teruel and colleagues, who reported smaller increases in free nuclear Ca^2+^/CaM levels compared with the cytosol in response to Ca^2+^ transients ([@bib92]). We have now cited their study in the manuscript.
